Jyong Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	0.13	0.1	0.18	0.72	0.55	3.56
Short-Term Investments	16.88	-	-	0.09	1.83	0.66
Cash & Short-Term Investments	17.01	0.1	0.18	0.81	2.39	4.22
Cash Growth	17615.63%	-44.63%	-78.20%	-65.95%	-43.51%	-
Prepaid Expenses	0.15	0.11	0.1	0.1	0.26	0.4
Restricted Cash	0	0	1.57	1.56	-	1.6
Total Current Assets	17.16	0.21	1.84	2.46	2.65	6.22
Property, Plant & Equipment	3.45	3.19	3.54	6	6.78	6.61
Long-Term Deferred Charges	-	0.93	0.72	0.28	-	-
Other Long-Term Assets	2.06	2.04	2.14	0.01	0.01	0.01
Total Assets	37.67	6.37	8.25	8.75	9.43	12.84
Accounts Payable	0	0	0	0	0.05	0.03
Accrued Expenses	1.21	1.32	1.14	0.86	1.06	0.65
Short-Term Debt	22.44	7.23	7.9	7.17	4.76	4.66
Current Portion of Long-Term Debt	0.35	0.06	0.08	0.48	0.18	0.17
Current Portion of Leases	0.13	0.16	0.13	0.17	0.25	0.13
Other Current Liabilities	3.43	3.37	5.02	4.22	0	0.15
Total Current Liabilities	27.55	12.13	14.26	12.91	6.29	5.78
Long-Term Debt	12.27	10.68	8.52	6.32	6.26	8.29
Long-Term Leases	0.01	0.02	0.07	0.12	0.35	0.36
Other Long-Term Liabilities	20.31	20.06	19.47	19.04	19.86	17.62
Total Liabilities	60.14	42.89	42.32	38.38	32.76	32.05
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	28.26	11.81	11.81	11.81	11.81	11.81
Retained Earnings	-34.33	-33.08	-30.06	-25.66	-19.03	-14.83
Treasury Stock	-16.37	-16.37	-16.37	-16.37	-16.37	-16.37
Comprehensive Income & Other	-0.04	1.12	0.55	0.59	0.27	0.19
Shareholders' Equity	-22.47	-36.52	-34.07	-29.63	-23.33	-19.2
Total Liabilities & Equity	37.67	6.37	8.25	8.75	9.43	12.84
Total Debt	35.19	18.14	16.69	14.25	11.79	13.6
Net Cash (Debt)	-18.19	-18.04	-16.51	-13.44	-9.4	-9.38
Net Cash Per Share	-0.25	-0.25	-0.23	-0.19	-0.13	-0.13
Filing Date Shares Outstanding	71.76	74.23	71.57	71.57	71.57	71.57
Total Common Shares Outstanding	71.76	71.57	71.57	71.57	71.57	71.57
Working Capital	-10.39	-11.92	-12.42	-10.44	-3.65	0.44
Book Value Per Share	-0.31	-0.51	-0.48	-0.41	-0.33	-0.27
Tangible Book Value	-22.47	-36.52	-34.07	-29.63	-23.33	-19.2
Tangible Book Value Per Share	-0.31	-0.51	-0.48	-0.41	-0.33	-0.27
Land	-	0.95	1.02	1.02	1.13	1.11
Buildings	-	2.48	2.65	2.64	2.93	2.89
Machinery	-	0.92	0.99	0.98	1.06	1.01
Construction In Progress	-	0.14	0.14	0.14	0.03	-
Leasehold Improvements	-	0.14	0.15	0.15	0.07	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q